From Pre-Approval to Post-Launch

End-to-End Commercialization Guide for Specialty Pharma

A practical guide to specialty pharma commercialization: government pricing, patient support programs, specialty pharmacy selection, and post-launch strategy.

Two Labs and Riparian, both part of Envision Pharma Group, work alongside specialty pharma manufacturers at nearly every stage of commercialization — government pricing and compliance, patient support programs, specialty pharmacy selection, trade and distribution, and post-launch optimization.

Each chapter of this guide was written by the experts who lead that work, drawing on real conversations with manufacturers navigating these decisions. Read this guide and you’ll walk into these same decisions with a clearer sense of what works, what tends to go wrong, and where to focus first.

What’s inside:

Download the eBook:

From Pre-Approval to Post-Launch ebook cover with the pre-launch readiness quick check sheet

Meet the experts

Will Pih

Will Pih

Co-Founder, Two Labs

Jennifer Lospinoso

Jennifer Lospinoso

President, Riparian

Aimee Bando-Bugosh

Aimee Bando-Bugosh

VP Patient Services, Two Labs

Anita Dopkosky

Anita Dopkosky

Vice President, Commercialization, Two Labs

Emily Campbell

Emily Campbell

Director of Training, Development, 
and Quality, Two Labs

Meggan Smith

Meggan Smith

Vice President, Commercialization, Two Labs

Susan Dunne

Susan Dunne

Managing Director,
Riparian